Jennifer Tseng, MD, MPH
Emeritus Professor
Boston University Chobanian & Avedisian School of Medicine
Surgery

MD, University of California, San Francisco
MPH, Harvard School of Public Health
BS, Stanford University
Websites
favorite icon LinkedIn




Dr. Tseng is a highly regarded surgical oncologist and gastrointestinal surgeon. She served as James Utley Professor and Chair of Surgery at the Boston University Chobanian & Avedisian School of Medicine and Surgeon-in-Chief at Boston Medical Center from 2017 until January 2024.

Dr. Tseng is a deputy editor of JAMA Surgery, a councilor on the American Board of Surgery, and past-President of the Society of Asian Academic Surgeons and of the Society for Surgery of the Alimentary Tract. She has published more than 150 peer-reviewed journal articles on reducing surgical risk, cancer biomarkers, and on developing models for cancer treatment sequencing strategies, with a strong focus on racial and socioeconomic disparities in care.

Dr. Tseng is also a dedicated educator of medical students and residents and has mentored numerous trainees throughout her career.


Health Care Utilization and Associated Costs Among Older Cancer Survivors
09/01/2022 - 09/30/2023 (Key Person / Mentor)
PI: Kelly M. Kenzik, MS PhD
American Cancer Society, Inc.




Title


Yr Title Project-Sub Proj Pubs
2001 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 5F32CA086420-02 3
2000 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 1F32CA086420-01 3

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Chang JH, Romatoski K, Torres MB, Sholevar CJ, Lindeman B, Gaskill C, Clark CN, Rocha F, Riall TS, Tseng JF, Davids JS, Pawlik TM, Walsh RM. GI Surgery Summit white paper: recruiting and training the next generation of surgeons. J Gastrointest Surg. 2025 Feb; 29(2):101896.View Related Profiles. PMID: 39580020
     
  2. Shatsky RA, Trivedi MS, Yau C, Nanda R, Rugo HS, Davidian M, Tsiatis B, Wallace AM, Chien AJ, Stringer-Reasor E, Boughey JC, Omene C, Rozenblit M, Kalinsky K, Elias AD, Vaklavas C, Beckwith H, Williams N, Arora M, Nangia C, Roussos Torres ET, Thomas B, Albain KS, Clark AS, Falkson C, Hershman DL, Isaacs C, Thomas A, Tseng J, Sanford A, Yeung K, Boles S, Chen YY, Huppert L, Jahan N, Parker C, Giridhar K, Howard FM, Blackwood MM, Sanft T, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Symmans WF, Price E, Heditsian D, LeStage B, Perlmutter J, Pohlmann P, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3737-3747. PMID: 39277672
     
  3. Khoury K, Meisel JL, Yau C, Rugo HS, Nanda R, Davidian M, Tsiatis B, Chien AJ, Wallace AM, Arora M, Rozenblit M, Hershman DL, Zimmer A, Clark AS, Beckwith H, Elias AD, Stringer-Reasor E, Boughey JC, Nangia C, Vaklavas C, Omene C, Albain KS, Kalinsky KM, Isaacs C, Tseng J, Roussos Torres ET, Thomas B, Thomas A, Sanford A, Balassanian R, Ewing C, Yeung K, Sauder C, Sanft T, Pusztai L, Trivedi MS, Outhaythip A, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Fraser Symmans W, Price E, Beedle C, Perlmutter J, Pohlmann P, Shatsky RA, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3728-3736. PMID: 39277671
     
  4. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle T, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Aug 13. PMID: 39138776
     
  5. Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC. ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy-Results from the I-SPY2 Clinical Trial. Ann Surg Oncol. 2024 Aug 03. PMID: 39097555
     
  6. Romatoski KS, de Geus SWL, Miriyam B, Chung SH, Kenzik K, Papageorge MV, Rasic G, Ng SC, Tseng JF, Sachs TE. ASO Visual Abstract: Overall Volume of Upper Gastrointestinal Surgery Positively Impacts Gastric Cancer Outcomes at Centers with Low Gastrectomy Volume. Ann Surg Oncol. 2024 Aug; 31(8):4952-4953.View Related Profiles. PMID: 38842677
     
  7. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7249-7259. PMID: 38995451; PMCID: PMC11452431; DOI: 10.1245/s10434-024-15792-x;
     
  8. Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC. Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7420-7428. PMID: 38980586
     
  9. Beaulieu-Jones BR, Ha EJ, Fefferman A, Wang J, Chung SH, Tseng JF, Merrill A, Sachs TE, Ko NY, Cassidy MR. ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann Surg Oncol. 2024 Jul 03.View Related Profiles. PMID: 38961042
     
  10. Romatoski KS, de Geus SWL, Miriyam B, Chung SH, Kenzik K, Papageorge MV, Rasic G, Ng SC, Tseng JF, Sachs TE. Overall Volume of Upper Gastrointestinal Surgery Positively Impacts Gastric Cancer Outcomes at Centers with Low Gastrectomy Volume. Ann Surg Oncol. 2024 Aug; 31(8):5293-5303.View Related Profiles. PMID: 38777899
     
Showing 10 of 225 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 225 publications over 27 distinct years, with a maximum of 22 publications in 2010

YearPublications
19951
19962
19972
19992
20001
20022
20042
20053
20063
20076
20086
200919
201022
20119
20127
20138
20144
20157
201615
201711
201813
20198
202015
202116
202211
202318
202412
Contact for Mentoring:
Tseng's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department